Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection

Journal of Investigative Dermatology

Volumn 132, Issue 12, 2012, Pages 2735-2743

  Gomes, Regis ^a   Oliveira, Fabiano ^a   Teixeira, Clarissa ^a   Meneses, Claudio ^a   Gilmore, Dana C ^a   Elnaiem, Dia Eldin ^b   Kamhawi, Shaden ^a   Valenzuela, Jesus G ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MARYLAND EASTERN SHORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LEISHMANIA VACCINE; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN LJM11; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IN VITRO STUDY; LEISHMANIA; LEISHMANIASIS; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; PROTEIN INDUCTION; TH1 CELL;

EID: 84870554772     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.205     Document Type: Article

References (20)

1. Belkaid Y, Kamhawi S, Modi G et al. (1998) Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 188:1941-53 (Pubitemid 28536781)
2. Bethony JM, Cole RN, Guo X et al. (2011) Vaccines to combat the neglected tropical diseases. Immunol Rev 239:237-70
3. Collin N, Gomes R, Teixeira C et al. (2009) Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania. PLoS Pathogens 5:e1000441
4. Darrah PA, Patel DT, De Luca PM et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13:843-50 (Pubitemid 47038186)
5. Gomes R, Teixeira C, Teixeira MJ et al. (2008) Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci USA 105:7845-50 (Pubitemid 351872726)
6. Handman E (2001) Leishmaniasis: current status of vaccine development. Clin Microbiol Rev 14:229-43 (Pubitemid 32294669)
7. Kamhawi S, Belkaid Y, Modi G et al. (2000) Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies. Science 290:1351-4
8. Lutz MB, Kukutsch N, Ogilvie AL et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77-92 (Pubitemid 29096240)
9. Oliveira F, Kamhawi S, Seitz AE et al. (2006) From transcriptome to immunome: identification of DTH inducing proteins from a Phlebotomus ariasi salivary gland cDNA library. Vaccine 24:374-90 (Pubitemid 41790441)
10. Oliveira F, Lawyer PG, Kamhawi S et al. (2008) Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Neglected Tropical Dis 2:e226
11. Peters NC, Egen JG, Secundino N et al. (2008) In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321:970-4
12. Peters NC, Kimblin N, Secundino N et al. (2009) Vector transmission of leishmania abrogates vaccine-induced protective immunity. PLoS Pathogens 5:e1000484
13. Rogers ME, Ilg T, Nikolaev AV et al. (2004) Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 430:463-7 (Pubitemid 38987909)
14. Rogers ME, Sizova OV, Ferguson MA et al. (2006) Synthetic glycovaccine protects against the bite of leishmania-infected sand flies. J Infect Dis 194:512-8 (Pubitemid 44162664)
15. Teixeira C, Gomes R, Collin N et al. (2010) Discovery of markers of exposure specific to bites of Lutzomyia longipalpis, the vector of Leishmania infantum chagasi in Latin America. PLoS Neglected Tropical Diseases 4:e638
16. Titus RG, Marchand M, Boon T et al. (1985) A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7:545-55 (Pubitemid 16256170)
17. Valenzuela JG, Belkaid Y, Garfield MK et al. (2001) Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein. J Exp Med 194:331-42 (Pubitemid 32730807)
18. Valenzuela JG, Garfield M, Rowton ED et al. (2004) Identification of the most abundant secreted proteins from the salivary glands of the sand fly Lutzomyia longipalpis, vector of Leishmania chagasi. J Exp Biol 207(Pt 21):3717-29 (Pubitemid 39484189)
19. WHO (2010) WHO Technical Report Series. www.WHO.intS
20. Xu X, Oliveira F, Chang BWet al. (2011) Structure and function of a "yellow" protein from saliva of the sand fly Lutzomyia longipalpis that confers protective immunity against Leishmania major infection. J Biol Chem 286:32383-93